Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Therapeutically Applicable Research to Generate Effective Treatments (TARGET) Initiative High-Risk Renal Tumor Project: Application of Array-Based Methods and Next Generation Sequencing to Identify Candidate Molecular Targets for High-Risk Wilms Tumors

NCT01118078 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT01118078
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01118078 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Therapeutically Applicable Research to Generate Effective Treatments (TARGET) Initiative High-Risk Renal Tumor Project: Application of Array-Based Methods and Next Generation Sequencing to Identify Candidate Molecular Targets for High-Risk Wilms Tumors
Lead sponsor
Children's Oncology Group
Phase
Observational
Overall status
Completed
Start date
May 31, 2010
Completion date
Not reported
Enrollment
185 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

clear cell sarcoma of the kidney, recurrent wilms tumor and other childhood kidney tumors, rhabdoid tumor of the kidney, stage i wilms tumor, stage ii wilms tumor, stage iii wilms tumor, stage iv wilms tumor, stage v wilms tumor